This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
novel coronavirus | 1726 |
acute respiratory | 702 |
coronavirus disease | 676 |
confirmed cases | 636 |
respiratory syndrome | 576 |
public health | 513 |
hubei province | 505 |
severe acute | 453 |
clinical characteristics | 447 |
granted medrxiv | 442 |
author funder | 442 |
copyright holder | 398 |
en el | 358 |
incubation period | 354 |
pacientes con | 298 |
syndrome coronavirus | 286 |
clinical features | 270 |
made available | 242 |
en pacientes | 238 |
control measures | 236 |
international license | 230 |
respiratory distress | 226 |
medrxiv preprint | 225 |
se recomienda | 222 |
coronavirus pneumonia | 220 |
los pacientes | 212 |
mainland china | 211 |
critically ill | 207 |
reproduction number | 202 |
patients infected | 198 |
distress syndrome | 193 |
wuhan city | 192 |
medical staff | 192 |
middle east | 191 |
hospitalized patients | 188 |
mental health | 187 |
con covid | 185 |
transmission dynamics | 183 |
risk factors | 182 |
world health | 179 |
east respiratory | 179 |
severe covid | 178 |
doc id | 178 |
cord uid | 178 |
systematic review | 174 |
human transmission | 172 |
healthcare workers | 171 |
health organization | 171 |
peer review | 170 |
social distancing | 167 |
health care | 162 |
health commission | 159 |
intensive care | 158 |
infected pneumonia | 158 |
nucleic acid | 157 |
new coronavirus | 157 |
confirmed covid | 156 |
ill patients | 156 |
united states | 154 |
chest ct | 154 |
version posted | 152 |
total number | 147 |
infectious disease | 147 |
spike protein | 145 |
infectious diseases | 144 |
infected patients | 139 |
basic reproduction | 138 |
en los | 137 |
national health | 134 |
rights reserved | 131 |
severe cases | 130 |
infected individuals | 128 |
infected cases | 128 |
coronavirus infection | 126 |
coronavirus outbreak | 125 |
contact tracing | 125 |
early stage | 125 |
seafood market | 124 |
without permission | 122 |
el uso | 121 |
reuse allowed | 120 |
allowed without | 120 |
suspected cases | 119 |
symptom onset | 119 |
outside hubei | 115 |
floating population | 114 |
huanan seafood | 113 |
del paciente | 113 |
new cases | 112 |
disease control | 111 |
epidemic spread | 109 |
severe patients | 108 |
cumulative number | 103 |
respiratory failure | 102 |
respiratory tract | 101 |
viral load | 101 |
reproductive number | 100 |
spring festival | 99 |
para el | 99 |
descriptive study | 97 |
clinical course | 97 |
protective equipment | 96 |
mortality rate | 95 |
el paciente | 95 |
por covid | 94 |
travel restrictions | 94 |
early transmission | 94 |
illness onset | 92 |
mechanical ventilation | 92 |
sars coronavirus | 92 |
con el | 92 |
case fatality | 91 |
cohort study | 90 |
hong kong | 89 |
outside wuhan | 89 |
serial interval | 88 |
global health | 87 |
cities outside | 87 |
care unit | 86 |
chinese government | 86 |
fatality rate | 85 |
lopinavir ritonavir | 85 |
pregnant women | 84 |
medical waste | 84 |
social media | 84 |
amino acid | 83 |
case series | 83 |
imported cases | 83 |
wuhan lockdown | 82 |
ncov infection | 81 |
median age | 81 |
close contact | 80 |
china clinical | 80 |
immune response | 80 |
ncov outbreak | 79 |
modelling study | 79 |
per day | 79 |
severe disease | 78 |
reported cases | 77 |
con sospecha | 76 |
converting enzyme | 76 |
first case | 76 |
cytokine storm | 74 |
authors declare | 73 |
person transmission | 72 |
personal protective | 72 |
death rate | 72 |
convalescent plasma | 72 |
family members | 71 |
sin embargo | 71 |
previous studies | 71 |
care workers | 71 |
paciente con | 71 |
family cluster | 70 |
retrospective study | 70 |
hospital admission | 70 |
statistically significant | 69 |
clinical trials | 69 |
lymphocyte count | 68 |
high risk | 68 |
new year | 68 |
spike glycoprotein | 67 |
south korea | 67 |
international spread | 67 |
epidemiological characteristics | 66 |
coronavirus infections | 66 |
con un | 66 |
en un | 65 |
early stages | 63 |
respiratory symptoms | 63 |
familial cluster | 63 |
receptor binding | 63 |
observational study | 62 |
social control | 62 |
clinical symptoms | 61 |
virus disease | 61 |
new infections | 61 |
clinical manifestations | 61 |
transmission rate | 60 |
may also | 60 |
respiratory disease | 60 |
close contacts | 60 |
critical care | 60 |
lf cases | 60 |
clinical outcomes | 59 |
pneumonia outbreak | 59 |
human mobility | 58 |
con una | 58 |
lung injury | 58 |
gastrointestinal symptoms | 58 |
common symptoms | 58 |
population movement | 57 |
upper respiratory | 57 |
seir model | 57 |
infection control | 57 |
real time | 57 |
disease severity | 57 |
present study | 57 |
virus infection | 57 |
medical resources | 57 |
viral rna | 56 |
pneumonia associated | 56 |
among patients | 56 |
significantly higher | 56 |
health emergency | 56 |
years old | 56 |
corona virus | 55 |
el manejo | 55 |
study clinical | 55 |
early phase | 54 |
confirmed case | 54 |
confirmed lf | 54 |
se debe | 54 |
standard deviation | 54 |
general population | 54 |
transmission rates | 54 |
air quality | 53 |
zhejiang province | 53 |
new york | 53 |
bat origin | 53 |
por sars | 53 |
coronavirus indicating | 53 |
confidence interval | 53 |
heart failure | 53 |
confirmed patients | 53 |
clinical trial | 53 |
weibo texts | 52 |
chinese cities | 52 |
cov infection | 52 |
ai system | 52 |
wholesale market | 52 |
interim guidance | 52 |
el riesgo | 52 |
pacientes en | 52 |
epidemic size | 52 |
reactive protein | 52 |
reproduction numbers | 52 |
un estudio | 51 |
se ha | 51 |
por el | 51 |
outbreak originating | 51 |
large number | 51 |
medical records | 51 |
seafood wholesale | 51 |
time pcr | 51 |
city population | 50 |
immune responses | 50 |
ct findings | 50 |
basic reproductive | 49 |
posted march | 49 |
mg kg | 49 |
dry cough | 49 |
infected people | 49 |
continuous variables | 48 |
potential domestic | 48 |
patients showed | 48 |
categorical variables | 47 |
clinical findings | 47 |
health authorities | 47 |
health interventions | 47 |
health problems | 47 |
respiratory infection | 47 |
human coronavirus | 47 |
situation report | 47 |
informed consent | 47 |
en las | 47 |
sample size | 47 |
orthopaedic surgeons | 46 |
se puede | 46 |
computed tomography | 46 |
retrospective cohort | 46 |
patients diagnosed | 46 |
factors associated | 46 |
logistic regression | 46 |
air pollution | 46 |
daily new | 46 |
two weeks | 46 |
epidemic situation | 46 |
cordon sanitaire | 46 |
indicating person | 46 |
medical care | 46 |
city lockdown | 45 |
mild symptoms | 45 |
cases reported | 45 |
wuhan municipal | 45 |
cuidados intensivos | 45 |
sars outbreak | 44 |
tested positive | 44 |
population flow | 44 |
publicly available | 44 |
viral pneumonia | 44 |
health measures | 44 |
face masks | 44 |
immune system | 44 |
mild cases | 43 |
infection cases | 43 |
hand hygiene | 43 |
severe group | 43 |
laboratory findings | 43 |
final size | 43 |
risk factor | 43 |
million people | 43 |
severe illness | 43 |
crisis management | 43 |
new confirmed | 43 |
el grupo | 43 |
old children | 43 |
membrane oxygenation | 43 |
intermediate host | 42 |
el tratamiento | 42 |
genome sequence | 42 |
chain reaction | 42 |
data collection | 42 |
travel history | 42 |
symptomatically infected | 42 |
severe pneumonia | 42 |
binding domain | 42 |
pharmaceutical interventions | 42 |
extracorporeal membrane | 42 |
organ failure | 42 |
lower respiratory | 42 |
pneumoniae isolates | 42 |
local transmission | 41 |
daily number | 41 |
also found | 41 |
anxiety disorder | 41 |
polymerase chain | 41 |
vaccine development | 41 |
excluding wuhan | 41 |
clinical management | 41 |
supplementary table | 41 |
emergency response | 41 |
kidney injury | 41 |
infection prevention | 40 |
critical cases | 40 |
closely related | 40 |
results showed | 40 |
competing interests | 40 |
data analysis | 40 |
median time | 40 |
por lo | 40 |
common cold | 40 |
disease progression | 39 |
cardiac injury | 39 |
chinese center | 39 |
plasma convaleciente | 39 |
higher risk | 39 |
disease outbreak | 39 |
recent study | 39 |
viral infection | 38 |
case report | 38 |
epidemic curve | 38 |
union hospital | 38 |
exported cases | 38 |
posted september | 38 |
mathematical model | 38 |
en una | 38 |
en cuenta | 38 |
social interaction | 38 |
ebola virus | 38 |
patients received | 38 |
poor outcome | 38 |
outside china | 38 |
even though | 38 |
secondary cases | 38 |
spatial distribution | 37 |
pao fio | 37 |
public awareness | 37 |
retrospective case | 37 |
within days | 37 |
china date | 37 |
exposure history | 37 |
first confirmed | 36 |
sore throat | 36 |
performed using | 36 |
patients outside | 36 |
henan province | 36 |
medical workers | 36 |
nan doi | 36 |
growth rate | 36 |
global pandemic | 36 |
pandemic influenza | 36 |
ct scans | 36 |
emerging infectious | 36 |
coronavirus associated | 36 |
epidemic control | 36 |
noninvasive ventilation | 36 |
significant difference | 36 |
first reported | 36 |
like coronavirus | 35 |
much higher | 35 |
potential total | 35 |
guangdong province | 35 |
severe critical | 35 |
multiple organ | 35 |
th february | 35 |
city travel | 35 |
ct images | 35 |
icu care | 35 |
ethics committee | 35 |
cumulative confirmed | 35 |
epidemiological parameters | 35 |
sleep disturbance | 35 |
population outflow | 35 |
exchange rate | 35 |
intervention strategies | 35 |
average number | 34 |
one patient | 34 |
since january | 34 |
virus transmission | 34 |
asymptomatic patients | 34 |
time series | 34 |
clinical severity | 34 |
adult patients | 34 |
current study | 34 |
important role | 34 |
asymptomatic infections | 34 |
time period | 34 |
personal protection | 34 |
pneumonia cases | 34 |
different countries | 34 |
bat sars | 34 |
adult inpatients | 34 |
infected population | 34 |
respiratory viruses | 34 |
septic shock | 34 |
normal range | 34 |
viral loads | 34 |
health concern | 34 |
first days | 34 |
clinical presentation | 34 |
wuhan university | 34 |
virus origins | 34 |
con los | 33 |
todos los | 33 |
respiratory infections | 33 |
patients admitted | 33 |
late january | 33 |
population movements | 33 |
disease caused | 33 |
laboratory tests | 33 |
two groups | 33 |
medical personnel | 33 |
final epidemic | 33 |
controlled trial | 33 |
pneumocystis jirovecii | 33 |
icu patients | 33 |
cell entry | 33 |
recovery rate | 33 |
different regions | 33 |
analysis showed | 33 |
negative suspected | 33 |
confidence intervals | 32 |
distancing measures | 32 |
supplementary material | 32 |
designated hospitals | 32 |
mobility data | 32 |
disease transmission | 32 |
stem cell | 32 |
unknown etiology | 32 |
sensitivity analysis | 32 |
susceptible individuals | 32 |
spread rate | 32 |
acute kidney | 32 |
coronavirus spike | 32 |
viral shedding | 32 |
antiviral treatment | 32 |
icu group | 32 |
epithelial cells | 32 |
throat swab | 32 |
antiviral therapy | 32 |
myocardial injury | 32 |
cardiovascular disease | 32 |
several studies | 31 |
traditional chinese | 31 |
doubling time | 31 |
lunar new | 31 |
outbreak associated | 31 |
control group | 31 |
atypical pneumonia | 31 |
included studies | 31 |
regression analysis | 31 |
genomic characterisation | 31 |
asymptomatic carriers | 31 |
probable bat | 31 |
randomized controlled | 31 |
available data | 31 |
increased risk | 31 |
odds ratio | 31 |
diamond princess | 31 |
glass opacity | 31 |
nursing staff | 31 |
mean incubation | 31 |
health crisis | 31 |
th january | 31 |
ct scan | 31 |
asymptomatic contact | 30 |
se han | 30 |
symptomatic cases | 30 |
glass opacities | 30 |
en uci | 30 |
widely used | 30 |
lassa fever | 30 |
study period | 30 |
related coronavirus | 30 |
ncov epidemic | 30 |
clinical data | 30 |
ground glass | 30 |
direct contact | 30 |
wuhan clinical | 30 |
diabetes mellitus | 30 |
transport station | 30 |
baidu migration | 30 |
zhongnan hospital | 30 |
respiratory diseases | 30 |
countries outside | 30 |
fatality risk | 30 |
en su | 30 |
cases outside | 30 |
age group | 30 |
vertical transmission | 30 |
chinese new | 30 |
posted october | 30 |
saudi arabia | 30 |
severely ill | 29 |
days later | 29 |
dehydrogenase type | 29 |
cruise ship | 29 |
ace receptor | 29 |
ct imaging | 29 |
inflammatory response | 29 |
regression model | 29 |
protective measures | 29 |
per capita | 29 |
los estudios | 29 |
case study | 29 |
reported confirmed | 29 |
preventive measures | 29 |
health workers | 29 |
every day | 29 |
transmission potential | 29 |
outside mainland | 29 |
patients may | 29 |
validation cohort | 29 |
su uso | 29 |
healthcare system | 29 |
novel coronaviruses | 28 |
respiratory specimens | 28 |
oxygen therapy | 28 |
cox regression | 28 |
face mask | 28 |
test results | 28 |
human respiratory | 28 |
statistical analysis | 28 |
wuhan residents | 28 |
driven analysis | 28 |
significantly lower | 28 |
como el | 28 |
intermediate hosts | 28 |
facemask use | 28 |
con sdra | 28 |
population density | 28 |
several limitations | 28 |
destination cities | 28 |
medical students | 28 |
household isolation | 28 |
pediatric patients | 28 |
international concern | 28 |
herd immunity | 28 |
protease inhibitor | 28 |
wind speed | 28 |
control strategies | 28 |
hospital staff | 28 |
debe ser | 28 |
fixed effects | 28 |
wuhan coronavirus | 28 |
time rt | 27 |
lactate dehydrogenase | 27 |
antiviral drugs | 27 |
ehv vaccine | 27 |
es un | 27 |
available online | 27 |
coronavirus diseases | 27 |
short period | 27 |
reverse transcription | 27 |
respiratory illness | 27 |
significant differences | 27 |
diagnosed cases | 27 |
puede ser | 27 |
exposed individuals | 27 |
pneumonia caused | 27 |
colistin resistance | 27 |
two months | 27 |
previous study | 27 |
may cause | 27 |
important lessons | 27 |
chinese medicine | 27 |
population inflow | 27 |
another study | 27 |
european countries | 27 |
laboratory testing | 27 |
major cities | 27 |
wild animals | 27 |
sleep quality | 27 |
municipal health | 27 |
negative patients | 27 |
del virus | 27 |
cases imported | 27 |
host cell | 26 |
coronavirus epidemic | 26 |
wuhan outbreak | 26 |
throat swabs | 26 |
attack rate | 26 |
travel restriction | 26 |
platelet count | 26 |
contact rate | 26 |
critical group | 26 |
infection rate | 26 |
social interactions | 26 |
semiformal organizations | 26 |
health status | 26 |
asymptomatic cases | 26 |
el cual | 26 |
two categories | 26 |
creatine kinase | 26 |
study showed | 26 |
phylogenetic analysis | 26 |
total population | 26 |
susceptible population | 26 |
time reverse | 26 |
data sources | 26 |
reported data | 26 |
additional file | 26 |
asymptomatically infected | 26 |
patients died | 26 |
big data | 26 |
ncov cases | 26 |
randomized clinical | 26 |
shelter hospitals | 26 |
chest computed | 26 |
pcr test | 25 |
correlation coefficient | 25 |
aspartate aminotransferase | 25 |
many patients | 25 |
recent studies | 25 |
three patients | 25 |
rural areas | 25 |
patients hospitalized | 25 |
cabin hospitals | 25 |
control policies | 25 |
trial version | 25 |
less likely | 25 |
infectious population | 25 |
el momento | 25 |
en este | 25 |
white blood | 25 |
ascertainment rate | 25 |
care medicine | 25 |
incubation periods | 25 |
highly contagious | 25 |
acute cardiac | 25 |
seasonal influenza | 25 |
lymphocyte ratio | 25 |
cuidado intensivo | 25 |
infectious period | 25 |
word categories | 25 |
invasive mechanical | 25 |
interquartile range | 25 |
quarantine measures | 25 |
transmission within | 25 |
avian influenza | 25 |
sars virus | 25 |
novel virus | 25 |
study population | 25 |
epidemiological data | 25 |
hydroxysteroid dehydrogenase | 25 |
el inicio | 25 |
acid negative | 25 |
suspected covid | 25 |
underlying diseases | 25 |
acid detection | 25 |
onset date | 25 |
klebsiella pneumoniae | 25 |
correlation analysis | 24 |
nosocomial transmission | 24 |
exponential growth | 24 |
medical facilities | 24 |
teniendo en | 24 |
prv infection | 24 |
many countries | 24 |
icu admission | 24 |
poor prognosis | 24 |
received antiviral | 24 |
viral infections | 24 |
en caso | 24 |
sectional study | 24 |
transmission risk | 24 |
igg antibodies | 24 |
spike proteins | 24 |
neutralizing antibodies | 24 |
alanine aminotransferase | 24 |
sobre el | 24 |
mitigation strategies | 24 |
en contra | 24 |
infections among | 24 |
human ace | 24 |
care homes | 24 |
epidemic model | 24 |
ncov pneumonia | 24 |
day mortality | 24 |
clinical diagnosis | 24 |
older age | 24 |
local outbreak | 24 |
monte carlo | 24 |
care providers | 24 |
medical supplies | 24 |
pulmonary disease | 24 |
infected persons | 24 |
training cohort | 24 |
kcal mole | 23 |
early diagnosis | 23 |
first two | 23 |
emerging coronaviruses | 23 |
original district | 23 |
anticancer treatment | 23 |
two patients | 23 |
chronic obstructive | 23 |
el tiempo | 23 |
incubation time | 23 |
normal distribution | 23 |
viral genome | 23 |
malayan pangolins | 23 |
previously reported | 23 |
mean age | 23 |
migration data | 23 |
infection prevalence | 23 |
si el | 23 |
semiformal control | 23 |
ph patients | 23 |
hubei provincial | 23 |
search index | 23 |
population size | 23 |
population mobility | 23 |
central china | 23 |
asymptomatic infection | 23 |
closed management | 23 |
pneumonia clinical | 23 |
acute lung | 23 |
supplementary information | 23 |
clinical studies | 23 |
network model | 23 |
recently emerged | 23 |
case definitions | 23 |
countries regions | 23 |
affected areas | 23 |
least one | 23 |
acid test | 23 |
first cases | 23 |
one case | 23 |
los casos | 23 |
central government | 23 |
binding site | 23 |
china novel | 23 |
tested negative | 23 |
across china | 23 |
el personal | 23 |
case reports | 23 |
line nurses | 23 |
seeking medical | 23 |
supplementary data | 23 |
wuhan seafood | 22 |
days earlier | 22 |
cumulative cases | 22 |
patients receiving | 22 |
index case | 22 |
psychological stress | 22 |
epidemic predictions | 22 |
es una | 22 |
developed symptoms | 22 |
corresponding author | 22 |
sars epidemic | 22 |
symptoms onset | 22 |
viral replication | 22 |
severe respiratory | 22 |
epidemic trend | 22 |
one month | 22 |
results show | 22 |
latent period | 22 |
also reported | 22 |
epidemic prevention | 22 |
travel ban | 22 |
patients without | 22 |
average daily | 22 |
novel human | 22 |
bilateral pneumonia | 22 |
mental fatigue | 22 |
urban areas | 22 |
consentimiento informado | 22 |
respiratory rate | 22 |
age groups | 22 |
wuhan pneumonia | 22 |
four cities | 22 |
community transmission | 22 |
study design | 22 |
new virus | 22 |
del estado | 22 |
related coronaviruses | 22 |
long time | 22 |
officially reported | 22 |
nasal cannula | 22 |
human coronaviruses | 22 |
science foundation | 22 |
generation spread | 22 |
oxygen saturation | 22 |
human origin | 21 |
influenza pandemic | 21 |
elderly patients | 21 |
transmission control | 21 |
local governments | 21 |
york city | 21 |
para los | 21 |
independent variables | 21 |
hospital stay | 21 |
obstructive pulmonary | 21 |
baseline scenario | 21 |
human health | 21 |
flow nasal | 21 |
falla respiratoria | 21 |
confirmed sars | 21 |
death cases | 21 |
resistance gene | 21 |
excluding hubei | 21 |
one week | 21 |
higher levels | 21 |
asymptomatic carrier | 21 |
public transport | 21 |
invasive ventilation | 21 |
infected individual | 21 |
total score | 21 |
study group | 21 |
body temperature | 21 |
regression analyses | 21 |
amino acids | 21 |
ace expression | 21 |
missing data | 21 |
subgroup analysis | 21 |
medical treatment | 21 |
will help | 21 |
relatively low | 21 |
health emergencies | 21 |
higher mortality | 21 |
early estimation | 21 |
reporting rate | 21 |
dose pm | 21 |
initial symptoms | 21 |
laboratory confirmed | 21 |
sequence identity | 21 |
might also | 21 |
outbreak risk | 21 |
animal models | 21 |
para pacientes | 21 |
coronavirus sars | 21 |
small number | 21 |
parameter values | 20 |
table shows | 20 |
spectrum antiviral | 20 |
infect humans | 20 |
instrumental variables | 20 |
en china | 20 |
human infection | 20 |
february th | 20 |
china coronavirus | 20 |
oral transmission | 20 |
among chinese | 20 |
may provide | 20 |
among medical | 20 |
lymphocyte subsets | 20 |
influencing factors | 20 |
people infected | 20 |
rapid spread | 20 |
transmission events | 20 |
virus spread | 20 |
public transportation | 20 |
scoring system | 20 |
es el | 20 |
estos pacientes | 20 |
liver injury | 20 |
state council | 20 |
type i | 20 |
para evitar | 20 |
immune function | 20 |
direct exposure | 20 |
research team | 20 |
emerging coronavirus | 20 |
imaging features | 20 |
innate immune | 20 |
generation sequencing | 20 |
china excluding | 20 |
antibody responses | 20 |
natural science | 20 |
generation spreads | 20 |
lo tanto | 20 |
routing problem | 20 |
january th | 20 |
value areas | 20 |
cleavage site | 20 |
tratamiento con | 20 |
highly infectious | 20 |
supportive care | 20 |
actual number | 20 |
diagnostic criteria | 20 |
average temperature | 20 |
using data | 20 |
initial ct | 20 |
central hospital | 20 |
treatment options | 20 |
care home | 20 |
elevated levels | 20 |
princess cruise | 20 |
nervous system | 20 |
higher level | 20 |
less severe | 20 |
symptoms included | 20 |
respiratory droplets | 20 |
epidemic threat | 20 |
cases per | 20 |
sir model | 20 |
suspected patients | 20 |
clinical practice | 20 |
es importante | 20 |
study found | 20 |
care units | 19 |
hospital beds | 19 |
candida auris | 19 |
bat coronavirus | 19 |
coronavirus cases | 19 |
public opinion | 19 |
host cells | 19 |
boltzmann function | 19 |
alto flujo | 19 |
weather conditions | 19 |
peak time | 19 |
coronavirus causing | 19 |
mathematical modelling | 19 |
household transmission | 19 |
prevention measures | 19 |
imported infection | 19 |
statistical analyses | 19 |
latest novel | 19 |
preliminary estimation | 19 |
interval distribution | 19 |
respiratory support | 19 |
within wuhan | 19 |
center study | 19 |
vehicle routing | 19 |
leaving wuhan | 19 |
health management | 19 |
second wave | 19 |
much lower | 19 |
relatively high | 19 |
province excluding | 19 |
involving patients | 19 |
antiviral activity | 19 |
focused coping | 19 |
median incubation | 19 |
recovered patients | 19 |
three different | 19 |
pulmonary arterial | 19 |
asymptomatic transmission | 19 |
united kingdom | 19 |
collected data | 19 |
cost function | 19 |
marginal contribution | 19 |
compared using | 19 |
spread rapidly | 19 |
initial number | 19 |
detection rate | 19 |
social distance | 19 |
posted may | 19 |
migrant workers | 19 |
infectious people | 19 |
disease dynamics | 19 |
multicenter study | 19 |
med doi | 19 |
among travellers | 19 |
analysis based | 19 |
peripheral blood | 19 |
influenza virus | 19 |
chest pain | 19 |
composite poor | 19 |
los cuales | 19 |
external validation | 19 |
entre los | 19 |
increasing number | 19 |
lockdown period | 19 |
see table | 19 |
least days | 19 |
monoclonal antibody | 19 |
cual se | 19 |
ill covid | 19 |
economic losses | 19 |
hasta el | 19 |
una serie | 19 |
search radius | 19 |
mobility patterns | 19 |
transport stations | 19 |
ace receptors | 19 |
coping behaviors | 19 |
rna viruses | 19 |
wuhan novel | 18 |
tratados con | 18 |
potential therapeutic | 18 |
also showed | 18 |
first hospital | 18 |
patients reported | 18 |
se sugiere | 18 |
cases may | 18 |
two cases | 18 |
structural proteins | 18 |
transmission route | 18 |
las recomendaciones | 18 |
different types | 18 |
exact test | 18 |
disease outbreaks | 18 |
case definition | 18 |
data collected | 18 |
southern china | 18 |
positive correlation | 18 |
healthcare providers | 18 |
also used | 18 |
family participants | 18 |
cuando se | 18 |
significantly different | 18 |
high level | 18 |
therapeutic options | 18 |
genomic characterization | 18 |
con enfermedad | 18 |
written informed | 18 |
china epidemiological | 18 |
forma rutinaria | 18 |
cases will | 18 |
infectious individuals | 18 |
side effects | 18 |
case numbers | 18 |
study date | 18 |
infected person | 18 |
management system | 18 |
yangtze river | 18 |
considered statistically | 18 |
pulmonary hypertension | 18 |
associated pneumonia | 18 |
case data | 18 |
th day | 18 |
care system | 18 |
clinical outcome | 18 |
particulate matter | 18 |
th percentile | 18 |
pneumococcal disease | 18 |
study also | 18 |
greatly reduced | 18 |
infectious cases | 18 |
recomienda en | 18 |
corticosteroid treatment | 18 |
acuerdo con | 18 |
arterial hypertension | 18 |
early december | 18 |
epidemiological history | 18 |
positive rate | 18 |
early outbreak | 18 |
survivor group | 18 |
included patients | 18 |
whole country | 18 |
los efectos | 18 |
organ dysfunction | 18 |
deceased patients | 18 |
em structure | 18 |
may lead | 18 |
suppression strategy | 18 |
working group | 18 |
pcr assay | 18 |
severe coronavirus | 18 |
joint mission | 18 |
potential intermediate | 18 |
without diabetes | 18 |
wuhan union | 18 |
plasma therapy | 18 |
resistance genes | 18 |
human beings | 18 |
school closure | 18 |
also find | 18 |
laboratory test | 18 |
early dynamics | 18 |
urgently needed | 18 |
global public | 17 |
una estrategia | 17 |
city closure | 17 |
infection may | 17 |
underlying disease | 17 |
likelihood function | 17 |
rapidly spread | 17 |
panic effect | 17 |
results indicate | 17 |
early february | 17 |
better understand | 17 |
whole genome | 17 |
crime control | 17 |
throughout china | 17 |
neutralizing antibody | 17 |
first week | 17 |
commonly used | 17 |
demographic characteristics | 17 |
patient care | 17 |
reference genome | 17 |
short time | 17 |
observational studies | 17 |
normally distributed | 17 |
del covid | 17 |
general public | 17 |
cases within | 17 |
festival holiday | 17 |
year holiday | 17 |
household quarantine | 17 |
many cities | 17 |
virus entry | 17 |
viral nucleic | 17 |
contar con | 17 |
case isolation | 17 |
dependent variable | 17 |
air travel | 17 |
china joint | 17 |
imported case | 17 |
emerged novel | 17 |
general facemask | 17 |
pcr assays | 17 |
positive cases | 17 |
publicly reported | 17 |
one day | 17 |
health england | 17 |
patients developed | 17 |
presumed asymptomatic | 17 |
respiratory viral | 17 |
health system | 17 |
sars patients | 17 |
control study | 17 |
respiratory syncytial | 17 |
four cases | 17 |
creative commons | 17 |
el estudio | 17 |
virus effect | 17 |
simulation results | 17 |
tongji hospital | 17 |
spatial correlation | 17 |
carrier transmission | 17 |
epidemic sources | 17 |
radiological findings | 17 |
symptomatic individuals | 17 |
radiological characteristics | 17 |
acid tests | 17 |
lo cual | 17 |
new disease | 17 |
antibiotic treatment | 17 |
regression models | 17 |
epidemiological investigation | 17 |
chloroquine phosphate | 17 |
en covid | 17 |
systematic reviews | 17 |
interaction control | 17 |
patients included | 17 |
disease spread | 17 |
newly infected | 16 |
pcr testing | 16 |
en estado | 16 |
among different | 16 |
river delta | 16 |
primary case | 16 |
low level | 16 |
series analysis | 16 |
global spread | 16 |
syncytial virus | 16 |
laboratory confirmation | 16 |
economic connection | 16 |
risk assessment | 16 |
perceived stress | 16 |
carga viral | 16 |
mobile phone | 16 |
fever clinic | 16 |
epidemiological control | 16 |
nosocomial infection | 16 |
immunosuppressive drugs | 16 |
social support | 16 |
pathological findings | 16 |
left wuhan | 16 |
mortality due | 16 |
desde el | 16 |
containment strategies | 16 |
mortality rates | 16 |
effectively inhibit | 16 |
specific antibodies | 16 |
prothrombin time | 16 |
comparado con | 16 |
infect dis | 16 |
si se | 16 |
city transmissions | 16 |
korean government | 16 |
manejo del | 16 |
blood cell | 16 |
unascertained cases | 16 |
swab samples | 16 |
like virus | 16 |
coronavirus study | 16 |
chinese health | 16 |
genome structure | 16 |
population distribution | 16 |
del tratamiento | 16 |
documented infections | 16 |
short term | 16 |
attentional region | 16 |
three cases | 16 |
data used | 16 |
fever clinics | 16 |
day survival | 16 |
cols en | 16 |
sars memory | 16 |
infected medical | 16 |
hunan province | 16 |
compromiso pulmonar | 16 |
han sido | 16 |
los trabajadores | 16 |
drug resistance | 16 |
large proportion | 16 |
las condiciones | 16 |
three cities | 16 |
heart disease | 16 |
previous reports | 16 |
information regarding | 16 |
containment measures | 16 |
two different | 16 |
chinese society | 16 |
preceding first | 16 |
reader study | 16 |
pneumonia emergency | 16 |
generalized anxiety | 16 |
prognostic factors | 16 |
collective response | 16 |
controlling covid | 16 |
four patients | 16 |
older patients | 16 |
cardiovascular diseases | 16 |
angiotensin system | 16 |
durante el | 16 |
una vez | 16 |
chloroquine effectively | 16 |
data sets | 16 |
capacitated vehicle | 16 |
health response | 16 |
results suggest | 16 |
electronic medical | 16 |
response epidemiology | 16 |
late december | 16 |
health systems | 16 |
demographic data | 16 |
including wuhan | 16 |
international committee | 16 |
government agencies | 16 |
government response | 15 |
gene mcr | 15 |
family outdoor | 15 |
para evaluar | 15 |
epidemiological features | 15 |
intravascular coagulation | 15 |
early warning | 15 |
epidemic models | 15 |
igm igg | 15 |
two cities | 15 |
times higher | 15 |
north america | 15 |
first identified | 15 |
chronic diseases | 15 |
acid residues | 15 |
myocardial infarction | 15 |
disseminated intravascular | 15 |
abnormal findings | 15 |
epidemic growth | 15 |
china cdc | 15 |
cause severe | 15 |
subgenus sarbecovirus | 15 |
higher compared | 15 |
cov outbreak | 15 |
las personas | 15 |
pneumoniae strains | 15 |
study reported | 15 |
also known | 15 |
medical team | 15 |
coagulation function | 15 |
resistance testing | 15 |
effective reproduction | 15 |
modeling study | 15 |
population flows | 15 |
chinese academy | 15 |
pueden ser | 15 |
underlying comorbidities | 15 |
early january | 15 |
outdoor restrictions | 15 |
cell transplantation | 15 |
ng ml | 15 |
newly identified | 15 |
antibody response | 15 |
provincial level | 15 |
pacientes covid | 15 |
healthcare staff | 15 |
receptor recognition | 15 |
flow data | 15 |
extended data | 15 |
onset dates | 15 |
diagnostic test | 15 |
highly effective | 15 |
peak occurs | 15 |
many cases | 15 |
time interval | 15 |
ant colony | 15 |
chinese lunar | 15 |
fold higher | 15 |
states clinical | 15 |
time points | 15 |
lunar calendar | 15 |
mild group | 15 |
entre el | 15 |
fangcang shelter | 15 |
disease prevention | 15 |
patients presented | 15 |
las medidas | 15 |
ace inhibitors | 15 |
las cuales | 15 |
different cities | 15 |
blood pressure | 15 |
viral diseases | 15 |
will also | 15 |
los servicios | 15 |
contact history | 15 |
stage one | 15 |
los recursos | 15 |
adaptive immune | 15 |
emitir una | 15 |
high levels | 15 |
pseudorabies virus | 15 |
newly confirmed | 15 |
prone positioning | 15 |
visceral leishmaniasis | 15 |
dificultad respiratoria | 15 |
survival probability | 15 |
crkp isolates | 15 |
epidemiological studies | 15 |
para su | 15 |
local public | 15 |
maximum likelihood | 15 |
el estado | 15 |
favor fundamento | 15 |
recomienda realizar | 15 |
measures implemented | 15 |
working hours | 15 |
first stage | 15 |
los niveles | 15 |
jirovecii pneumonia | 15 |
period distribution | 15 |
medical history | 15 |
control mechanisms | 15 |
largest number | 15 |
host immune | 15 |
impact assessment | 15 |
symptomatic transmission | 15 |
city i | 15 |
migration index | 15 |
develop severe | 15 |
dis doi | 15 |
orf ab | 15 |
hc model | 15 |
mobility restrictions | 15 |
patients might | 15 |
medical institutions | 15 |
prone position | 15 |
pacientes hospitalizados | 15 |
local government | 15 |
pneumonia patients | 15 |
college students | 15 |
disease risk | 14 |
commons attribution | 14 |
study cohort | 14 |
two centers | 14 |
con las | 14 |
cases increased | 14 |
healthcare professionals | 14 |
festival travel | 14 |
ncov spike | 14 |
como una | 14 |
early cases | 14 |
key parameters | 14 |
mobile devices | 14 |
also considered | 14 |
recent report | 14 |
con pacientes | 14 |
study using | 14 |
prospective study | 14 |
bat coronaviruses | 14 |
donde se | 14 |
statistical significance | 14 |
initial stage | 14 |
gamma distribution | 14 |
crucial role | 14 |
hospital mortality | 14 |
healthcare services | 14 |
antibody tests | 14 |
chinese medical | 14 |
national natural | 14 |
single center | 14 |
combination therapy | 14 |
significantly reduced | 14 |
weather variables | 14 |
model based | 14 |
del uso | 14 |
medical college | 14 |
significant impact | 14 |
data extraction | 14 |
asociado con | 14 |
pandemia covid | 14 |
individual isolation | 14 |
outbreak period | 14 |
south china | 14 |
disease burden | 14 |
wide range | 14 |
psychological impact | 14 |
daily confirmed | 14 |
quickly spread | 14 |
studies reported | 14 |
one study | 14 |
different scenarios | 14 |
estimated number | 14 |
nucleocapsid protein | 14 |
coronavirus isolated | 14 |
el traslado | 14 |
days prior | 14 |
huazhong university | 14 |
es necesario | 14 |
two days | 14 |
positive effects | 14 |
seeking help | 14 |
initial confirmed | 14 |
clinical microbiology | 14 |
affected people | 14 |
anal swabs | 14 |
bronchoalveolar lavage | 14 |
level cities | 14 |
substitution sites | 14 |
since december | 14 |
causative agent | 14 |
online version | 14 |
zoonotic spillover | 14 |
destination city | 14 |
deben ser | 14 |
pearson correlation | 14 |
transportation restriction | 14 |
inflow population | 14 |
different sources | 14 |
asian countries | 14 |
economic output | 14 |
positive results | 14 |
cellular immune | 14 |
may help | 14 |
effective vaccine | 14 |
mild disease | 14 |
rapid increase | 14 |
signs symptoms | 14 |
jiangsu province | 14 |
common symptom | 14 |
right truncation | 14 |
develop symptoms | 14 |
por coronavirus | 14 |
liver function | 14 |
wavelet coherence | 14 |
microbiology reviews | 14 |
muscle ache | 14 |
stool samples | 14 |
waste management | 14 |
reported covid | 14 |
pressure ventilation | 14 |
el sars | 14 |
medical teams | 14 |
coronavirus covid | 14 |
protective clothing | 14 |
transcription polymerase | 14 |
mathematical modeling | 14 |
neurological symptoms | 14 |
several days | 14 |
data set | 14 |
del personal | 14 |
ha sido | 14 |
wuhan diary | 14 |
human cells | 14 |
immune cells | 14 |
critical illness | 14 |
current outbreak | 14 |
genome sequencing | 14 |
corticosteroid therapy | 14 |
en paciente | 14 |
hubei cities | 14 |
laboratory results | 14 |
evacuation flights | 14 |
severe anxiety | 14 |
second weeks | 14 |
immunocompromised patients | 14 |
contact patterns | 14 |
lower bound | 14 |
sputum production | 14 |
el consentimiento | 13 |
gdp per | 13 |
hospitalizados con | 13 |
dimer levels | 13 |
ct features | 13 |
cerebrovascular disease | 13 |
patchy shadows | 13 |
cell count | 13 |
stress load | 13 |
alto riesgo | 13 |
first covid | 13 |
nonsevere group | 13 |
early detection | 13 |
kernel density | 13 |
differential equations | 13 |
negative results | 13 |
un mayor | 13 |
home quarantine | 13 |
isolation wards | 13 |
analysis indicated | 13 |
lockdown self | 13 |
los criterios | 13 |
mental healthcare | 13 |
chinese authorities | 13 |
lessons learned | 13 |
positive result | 13 |
analysis revealed | 13 |
cell rna | 13 |
health seeking | 13 |
like coronaviruses | 13 |
deep learning | 13 |
epidemic period | 13 |
node degrees | 13 |
coronavirus replication | 13 |
methods section | 13 |
pcr results | 13 |
large numbers | 13 |
severe symptoms | 13 |
literature search | 13 |
type covid | 13 |
emergency department | 13 |
wet markets | 13 |
aged years | 13 |
final manuscript | 13 |
article distributed | 13 |
bilateral lung | 13 |
analysis clinical | 13 |
new type | 13 |
basado en | 13 |
synthetic vaccines | 13 |
novel sars | 13 |
gender difference | 13 |
modified seir | 13 |
key dates | 13 |
airway pressure | 13 |
retrospective review | 13 |
mountain hospital | 13 |
traffic data | 13 |
wuhan china | 13 |
economic loss | 13 |
taking suppression | 13 |
may play | 13 |
para sars | 13 |
physical fatigue | 13 |
increased rapidly | 13 |
con hipoxemia | 13 |
live animal | 13 |
infection risk | 13 |
en cuanto | 13 |
pcr tests | 13 |
temporal changes | 13 |
cases exported | 13 |
local travel | 13 |
neurological manifestations | 13 |
early human | 13 |
human movement | 13 |
real world | 13 |
abdominal pain | 13 |
falla renal | 13 |
transmission model | 13 |
wuhan may | 13 |
medical help | 13 |
el objetivo | 13 |
mers coronavirus | 13 |
public places | 13 |
consecutive patients | 13 |
takes value | 13 |
undocumented infection | 13 |
start date | 13 |
disminuir el | 13 |
epidemic data | 13 |
critical patients | 13 |
new infection | 13 |
disease information | 13 |
antiviral drug | 13 |
china covid | 13 |
capital city | 13 |
estancia en | 13 |
around january | 13 |
determine whether | 13 |
detailed information | 13 |
del sistema | 13 |
con respecto | 13 |
prefusion conformation | 13 |
virus transmissions | 13 |
tracheal intubation | 13 |
dromedary camels | 13 |
laboratory data | 13 |
generation infection | 13 |
un protocolo | 13 |
health committee | 13 |
cases identified | 13 |
among people | 13 |
th march | 13 |
serial intervals | 13 |
disease onset | 13 |
infected subjects | 13 |
first report | 13 |
clinical manifestation | 13 |
type diabetes | 13 |
markov chain | 13 |
behavioral responses | 13 |
patients aged | 13 |
expert consensus | 13 |
may result | 13 |
adults hospitalized | 13 |
within hubei | 13 |
developed severe | 13 |
age distribution | 13 |
mathematical models | 13 |
horseshoe bats | 13 |
like symptoms | 13 |
local residents | 13 |
credible interval | 13 |
latent time | 13 |
mulbsta score | 13 |
ncov virus | 13 |
treating patients | 13 |
epidemic dynamics | 13 |
receptor ace | 13 |
ncov transmission | 13 |
dipeptidyl peptidase | 13 |
chinese spring | 13 |
lung involvement | 13 |
study conducted | 13 |
healthcare demand | 13 |
pharyngeal swab | 13 |
attentional regions | 12 |
tract infections | 12 |
events notification | 12 |
en salud | 12 |
chronic hepatitis | 12 |
viral entry | 12 |
informal control | 12 |
pertussis infection | 12 |
bal fluid | 12 |
including hypertension | 12 |
commercially available | 12 |
endotracheal intubation | 12 |
clinical predictors | 12 |
epidemiology team | 12 |
patients recovered | 12 |
accessory proteins | 12 |
independently associated | 12 |
supporting information | 12 |
total cases | 12 |
china national | 12 |
pj pcr | 12 |
worth noting | 12 |
blood tests | 12 |
klebsiella species | 12 |
pneumonia diagnosis | 12 |
cuenta con | 12 |
high mortality | 12 |
scientific community | 12 |
wuhan using | 12 |
access article | 12 |
synthetic vaccine | 12 |
sustained transmission | 12 |
rna polymerase | 12 |
ace binding | 12 |
related weibo | 12 |
lavage fluid | 12 |
therapeutic efficacy | 12 |
health officials | 12 |
epidemiologic characteristics | 12 |
el rendimiento | 12 |
cesarean section | 12 |
calculated using | 12 |
first time | 12 |
identified coronavirus | 12 |
median duration | 12 |
patients treated | 12 |
epidemic will | 12 |
external test | 12 |
next day | 12 |
chain monte | 12 |
hot spots | 12 |
las muestras | 12 |
serum creatinine | 12 |
final version | 12 |
frecuencia respiratoria | 12 |
ongoing wuhan | 12 |
effective treatment | 12 |
average age | 12 |
visiting wuhan | 12 |
emergency use | 12 |
swab specimens | 12 |
paediatric healthcare | 12 |
first symptoms | 12 |
travel rush | 12 |
pacientes recibieron | 12 |
serological tests | 12 |
lymphocyte counts | 12 |
asymptomatic individuals | 12 |
healthcare facilities | 12 |
cov spike | 12 |
blood urea | 12 |
tracing process | 12 |
herpesvirus type | 12 |
fourth weeks | 12 |
uso del | 12 |
el contexto | 12 |
study included | 12 |
human prv | 12 |
communist party | 12 |
provide valuable | 12 |
cumulative numbers | 12 |
health problem | 12 |
retrospective analysis | 12 |
recovered cases | 12 |
encoding genes | 12 |
pulmonary edema | 12 |
coronavirus genome | 12 |
equine herpesvirus | 12 |
mayor riesgo | 12 |
outcomes among | 12 |
pneumonia epidemic | 12 |
linear regression | 12 |
high prevalence | 12 |
expected number | 12 |
hospitalized children | 12 |
coronavirus hku | 12 |
krsfiedllfnkv motif | 12 |
two independent | 12 |
acute myocardial | 12 |
incineration plants | 12 |
complex networks | 12 |
model parameters | 12 |
digestive symptoms | 12 |
diagnostic tests | 12 |
tract infection | 12 |
correlation characteristics | 12 |
mobile facilities | 12 |
puede emitir | 12 |
quarantined cases | 12 |
outbreak size | 12 |
connection intensity | 12 |
grupo control | 12 |
american society | 12 |
deaths per | 12 |
partial pressure | 12 |
sensitivity analyses | 12 |
expert group | 12 |
effective measures | 12 |
mitigation measures | 12 |
high consequence | 12 |
daily reproduction | 12 |
wuhan cities | 12 |
exclusion criteria | 12 |
wuhan epidemiological | 12 |
city mobility | 12 |
initial cases | 12 |
species transmission | 12 |
estimated using | 12 |
functional receptor | 12 |
necrosis factor | 12 |
las primeras | 12 |
slightly higher | 12 |
travel medicine | 12 |
supplementary materials | 12 |
emerging viruses | 12 |
epidemic threshold | 12 |
spread throughout | 12 |
secondary infections | 12 |
hospital infection | 12 |
transmission network | 12 |
antibiotic resistance | 12 |
tener en | 12 |
pathogenic coronavirus | 12 |
measures including | 12 |
cr strains | 12 |
live animals | 12 |
making donations | 12 |
prediction model | 12 |
risk group | 12 |
best fit | 12 |
samples collected | 12 |
many studies | 12 |
peer reviewed | 12 |
renal aguda | 12 |
well known | 12 |
standard deviations | 12 |
negative thoughts | 12 |
chinese national | 12 |
second week | 12 |
still unknown | 12 |
chinese cdc | 12 |
one hand | 12 |
igm antibody | 12 |
washington state | 12 |
los primeros | 12 |
population migration | 12 |
symptomatic case | 12 |
moderate group | 12 |
secondary bacterial | 12 |
novel corona | 12 |
substantial undocumented | 12 |
ct manifestations | 12 |
rheumatic patients | 12 |
large scale | 12 |
density function | 12 |
china characteristics | 12 |
wet market | 12 |
clinical signs | 12 |
measures taken | 12 |
hcv genotype | 12 |
incidence rate | 12 |
los resultados | 12 |
pulmonary embolism | 11 |
springer nature | 11 |
different time | 11 |
nine pregnant | 11 |
mixed isolation | 11 |
wuhan early | 11 |
con mayor | 11 |
outflow population | 11 |
lung cancer | 11 |
potentially infected | 11 |
protease inhibitors | 11 |
limited data | 11 |
venous thromboembolism | 11 |
quarantine period | 11 |
new covid | 11 |
also included | 11 |
approximately days | 11 |
supportive treatment | 11 |
remains neutral | 11 |
initial infectious | 11 |
patients undergoing | 11 |
target cells | 11 |
wearing face | 11 |
central nervous | 11 |
preterm delivery | 11 |
como los | 11 |
early epidemiological | 11 |
epi isl | 11 |
weibo users | 11 |
highest number | 11 |
much smaller | 11 |
including sars | 11 |
negative cases | 11 |
del equipo | 11 |
virus particles | 11 |
recent pneumonia | 11 |
terminal domain | 11 |
like sars | 11 |
rapid detection | 11 |
initial virological | 11 |
infectious rate | 11 |
cardiovascular complications | 11 |
endemic areas | 11 |
less common | 11 |
western medicine | 11 |
pneumonia prevention | 11 |
human transmissions | 11 |
death toll | 11 |
medical sciences | 11 |
maximum temperature | 11 |
current epidemic | 11 |
italian liwc | 11 |
delay distributions | 11 |
suspected sars | 11 |
day quarantine | 11 |
informal groups | 11 |
china seafood | 11 |
across cities | 11 |
rhesus macaques | 11 |
reported case | 11 |
timely treatment | 11 |
enfermedad severa | 11 |
main reason | 11 |
potential exposure | 11 |
nature remains | 11 |
mean time | 11 |
previous months | 11 |
data base | 11 |
three coefficients | 11 |
psychological distress | 11 |
mixing patterns | 11 |
spread among | 11 |
review board | 11 |
local medical | 11 |
even higher | 11 |
one new | 11 |
detection factors | 11 |
severely affected | 11 |
el nivel | 11 |
los medicamentos | 11 |
pacientes tratados | 11 |
literature review | 11 |
estudio retrospectivo | 11 |
situation reports | 11 |
first imported | 11 |
clinical samples | 11 |
negative pressure | 11 |
institutional affiliations | 11 |
blood samples | 11 |
respiratorio agudo | 11 |
note springer | 11 |
younger patients | 11 |
several cases | 11 |
positive airway | 11 |
erythrocyte sedimentation | 11 |
high school | 11 |
social networks | 11 |
associated coronavirus | 11 |
beds per | 11 |
jurisdictional claims | 11 |
ct volumes | 11 |
effective quarantine | 11 |
front line | 11 |
huanan market | 11 |
allows us | 11 |
less frequent | 11 |
un paciente | 11 |
outbreak investigation | 11 |
important factor | 11 |
outbreak started | 11 |
zoonotic coronaviruses | 11 |
author contributions | 11 |
reduced dose | 11 |
topic extraction | 11 |
future outbreaks | 11 |
treatment regimens | 11 |
urgent need | 11 |
six patients | 11 |
three groups | 11 |
control mechanism | 11 |
disease spreading | 11 |
el fin | 11 |
existe una | 11 |
following criteria | 11 |
statistical computing | 11 |
opening remarks | 11 |
cell receptor | 11 |
hospital bed | 11 |
higher values | 11 |
unknown cause | 11 |
causing respiratory | 11 |
clinically diagnosed | 11 |
data fitting | 11 |
angiotensin ii | 11 |
cytokine storms | 11 |
human airway | 11 |
imperial college | 11 |
cytokine release | 11 |
por un | 11 |
long structural | 11 |
smoking history | 11 |
reduced pm | 11 |
angiotensin converting | 11 |
three days | 11 |
related factors | 11 |
relatively mild | 11 |
recomienda el | 11 |
human sars | 11 |
physical examination | 11 |
viral genomes | 11 |
gastrointestinal tract | 11 |
environmental conditions | 11 |
acquired pneumonia | 11 |
significant role | 11 |
efectos adversos | 11 |
control program | 11 |
among covid | 11 |
ha demostrado | 11 |
observational cohort | 11 |
aumento en | 11 |
younger people | 11 |
infection status | 11 |
large sample | 11 |
apparent efficacy | 11 |
within china | 11 |
health doi | 11 |
human cases | 11 |
findings suggest | 11 |
hypoxemic respiratory | 11 |
clinical specimens | 11 |
cerebrovascular diseases | 11 |
parameter estimation | 11 |
los siguientes | 11 |
potential bat | 11 |
first patients | 11 |
homologous recombination | 11 |
human infections | 11 |
around wuhan | 11 |
st january | 11 |
elderly people | 11 |
longer incubation | 11 |
severe conditions | 11 |
epidemic trends | 11 |
life support | 11 |
blood cells | 11 |
este estudio | 11 |
june th | 11 |
early epidemic | 11 |
introduction index | 11 |
personal response | 11 |
laboratory abnormalities | 11 |
previously described | 11 |
response team | 11 |
leishenshan hospital | 11 |
population inflows | 11 |
cuidados paliativos | 11 |
structural studies | 11 |
standard errors | 11 |
published maps | 11 |
generation cases | 11 |
unknown origin | 11 |
model using | 11 |
cardiovascular system | 11 |
tidal volume | 11 |
renal function | 11 |
city fixed | 11 |
control efforts | 11 |
chest radiography | 11 |
kawasaki disease | 11 |
pcr result | 11 |
recently published | 11 |
estimating clinical | 11 |
abnormal coagulation | 11 |
healthcare settings | 11 |
different stages | 11 |
medical conditions | 11 |
ncov infected | 11 |
potential risk | 11 |
secondary transmission | 11 |
outbreak data | 11 |
educational level | 11 |
stage two | 11 |
ncov infections | 11 |
traffic accessibility | 11 |
jinyintan hospital | 11 |
changsha city | 11 |
study used | 11 |
relative risk | 11 |
ill cases | 11 |
test cohort | 11 |
con tcz | 11 |
increased mortality | 11 |
nitric oxide | 11 |
quarantine rate | 11 |
release syndrome | 11 |
therapeutic strategies | 10 |
relacionadas con | 10 |
emerging disease | 10 |
local spatial | 10 |
bone marrow | 10 |
species barrier | 10 |
previous day | 10 |
new case | 10 |
spss inc | 10 |
formal organizations | 10 |
west africa | 10 |
bilateral patchy | 10 |
two hospitals | 10 |
care systems | 10 |
analysis suggested | 10 |
become infected | 10 |
city level | 10 |
como un | 10 |
dynamic changes | 10 |
two variables | 10 |
transmission probability | 10 |
risk areas | 10 |
entry depends | 10 |
treatment facilities | 10 |
may still | 10 |
local healthcare | 10 |
el virus | 10 |
patients requiring | 10 |
serine protease | 10 |
infection transmission | 10 |
high rate | 10 |
investigation team | 10 |
tracto respiratorio | 10 |
una mayor | 10 |
tumor necrosis | 10 |
recall bias | 10 |
much less | 10 |
johns hopkins | 10 |
study early | 10 |
rna genome | 10 |
case importation | 10 |
human proteins | 10 |
per week | 10 |
mean value | 10 |
nucleotide identity | 10 |
suspected case | 10 |
tomar decisiones | 10 |
high viral | 10 |
severe infection | 10 |
rna virus | 10 |
regression coefficient | 10 |
whole world | 10 |
effective reproductive | 10 |
predicted number | 10 |
coefficient estimate | 10 |
innate immunity | 10 |
million passengers | 10 |
using real | 10 |
east asia | 10 |
asymptomatic covid | 10 |
coagulation parameters | 10 |
debe considerar | 10 |
recomienda considerar | 10 |
spearman correlation | 10 |
european centre | 10 |
el primer | 10 |
family coronaviridae | 10 |
treat covid | 10 |
risk exposures | 10 |
different levels | 10 |
future studies | 10 |
en esta | 10 |
tract specimens | 10 |
recomienda utilizar | 10 |
en estos | 10 |
disease outcomes | 10 |
two parameters | 10 |
hospitalized covid | 10 |
current evidence | 10 |
risk groups | 10 |
real data | 10 |
environmental reservoir | 10 |
generation time | 10 |
per minute | 10 |
las horas | 10 |
surviving sepsis | 10 |
individuals may | 10 |
iv regressions | 10 |
similar patterns | 10 |
quality index | 10 |
public spaces | 10 |
formal control | 10 |
time point | 10 |
suspected human | 10 |
facilities conditions | 10 |
great importance | 10 |
travel bans | 10 |
median score | 10 |
previous paper | 10 |
codon usage | 10 |
eventos adversos | 10 |
intrauterine vertical | 10 |
en algunos | 10 |
local cases | 10 |
los respiradores | 10 |
normal level | 10 |
se pueden | 10 |
cases without | 10 |
protein sequence | 10 |
hipoxemia refractaria | 10 |
near future | 10 |
severe sars | 10 |
authors contributed | 10 |
igg positivity | 10 |
log distance | 10 |
mild covid | 10 |
exposed population | 10 |
study involving | 10 |
first day | 10 |
twitter users | 10 |
patients suffering | 10 |
ws network | 10 |
first author | 10 |
recent insights | 10 |
infection fatality | 10 |
public panic | 10 |
male sex | 10 |
health services | 10 |
controlled trials | 10 |
membrane fusion | 10 |
wearing masks | 10 |
infection pressure | 10 |
pcr para | 10 |
search volume | 10 |
multivariate analysis | 10 |
clear evidence | 10 |
showed bilateral | 10 |
pneumonia coronavirus | 10 |
nearby cities | 10 |
ethical approval | 10 |
comparative analysis | 10 |
negative effect | 10 |
also demonstrated | 10 |
informal social | 10 |
zoonotic origin | 10 |
enfermedad por | 10 |
strict quarantine | 10 |
adverse effects | 10 |
sequence alignment | 10 |
reduce transmission | 10 |
todo el | 10 |
past days | 10 |
pulmonary fibrosis | 10 |
node degree | 10 |
extended chain | 10 |
research group | 10 |
sectional survey | 10 |
public concern | 10 |
collect data | 10 |
wuhan hubei | 10 |
daily numbers | 10 |
series clinical | 10 |
cases decreased | 10 |
realizar el | 10 |
rapid dissemination | 10 |
infections involving | 10 |
case counts | 10 |
institutional ethics | 10 |
lockdown effect | 10 |
cell surface | 10 |
sobre los | 10 |
present paper | 10 |
en tiempos | 10 |
immunosuppressive therapies | 10 |
recipient country | 10 |
wuhan population | 10 |
recently reported | 10 |
induced lung | 10 |
treatment measures | 10 |
ill adults | 10 |
palm civets | 10 |
hospital settings | 10 |
symptomatic patients | 10 |
observed data | 10 |
respiratoria aguda | 10 |
un modelo | 10 |
material associated | 10 |
coronavirus emerging | 10 |
los epp | 10 |
air pollutants | 10 |
people leaving | 10 |
anxiety disorders | 10 |
antiviral agents | 10 |
novel cov | 10 |
consensus statement | 10 |
poisson distribution | 10 |
proven protease | 10 |
cpc members | 10 |
sought medical | 10 |
open access | 10 |
animal markets | 10 |
younger age | 10 |
stranded rna | 10 |
recovered individuals | 10 |
population data | 10 |
pathogenic coronaviruses | 10 |
ser una | 10 |
treatment capacity | 10 |
sepsis campaign | 10 |
en wuhan | 10 |
second stage | 10 |
clinical research | 10 |
three months | 10 |
healthcare systems | 10 |
first half | 10 |
peak value | 10 |
weibull distribution | 10 |
estancia hospitalaria | 10 |
waste disposal | 10 |
virus outbreak | 10 |
phase iii | 10 |
becoming infected | 10 |
inner mongolia | 10 |
del plasma | 10 |
severe ards | 10 |
network structure | 10 |
time delay | 10 |
highly sensitive | 10 |
genome sequences | 10 |
infection data | 10 |
total bilirubin | 10 |
intravenous immunoglobulin | 10 |
nasopharyngeal swabs | 10 |
one person | 10 |
colony algorithm | 10 |
syndrome associated | 10 |
emergency management | 10 |
based vaccine | 10 |
will need | 10 |
animal market | 10 |
critical covid | 10 |
closure period | 10 |
el punto | 10 |
sedimentation rate | 10 |
intervention group | 10 |
also observed | 10 |
sars cov | 10 |
posted june | 10 |
independent predictors | 10 |
higher proportion | 10 |
disease clinical | 10 |
respiratory complications | 10 |
puede considerar | 10 |
exact date | 10 |
international health | 10 |
human angiotensin | 10 |
bamboo rat | 10 |
may boost | 10 |
also examined | 10 |
emerging respiratory | 10 |
animal species | 10 |
value method | 10 |
disease covid | 10 |
work environment | 10 |
seir models | 10 |
lung tissue | 10 |
positive pressure | 10 |
front lines | 10 |
one might | 10 |
dependent rna | 10 |
lognormal distribution | 10 |
large amount | 10 |
sustained human | 10 |
reduce covid | 10 |
wuhan within | 10 |
testing capacity | 10 |
current trend | 10 |
therapeutic agents | 10 |
decision making | 10 |
rd january | 10 |
escherichia coli | 10 |
sporadic cases | 10 |
salud mental | 10 |
previously known | 10 |
two sub | 10 |
recombination within | 10 |
become available | 10 |
interactive web | 10 |
fisher exact | 10 |
lockdown group | 10 |
antiviral therapies | 9 |
patienten mit | 9 |
mildly symptomatic | 9 |
pcr detection | 9 |
wuchang district | 9 |
relatively small | 9 |
el plasma | 9 |
male patients | 9 |
pj carriers | 9 |
existing literature | 9 |
prv wild | 9 |
tongji medical | 9 |
envelope protein | 9 |
like covs | 9 |
convalescent sera | 9 |
wuhan participants | 9 |
interquartile ranges | 9 |
review status | 9 |
control groups | 9 |
reported deaths | 9 |
roc curve | 9 |
fang fang | 9 |
log cfu | 9 |
mediated colistin | 9 |
oxygen supply | 9 |
troponin i | 9 |
hospital discharge | 9 |
epidemiologic parameters | 9 |
resistant klebsiella | 9 |
coping style | 9 |
current pandemic | 9 |
taking necessary | 9 |
two types | 9 |
berlin definition | 9 |
emergency committee | 9 |
immune algorithm | 9 |
three dimensional | 9 |
del tracto | 9 |
significantly decreased | 9 |
novel coronavirusinfected | 9 |
mean difference | 9 |
study covid | 9 |
laboratory parameters | 9 |
studies conducted | 9 |
infection clinical | 9 |
medical university | 9 |
information file | 9 |
neonates born | 9 |
clinical evidence | 9 |
active anticancer | 9 |
transmission patterns | 9 |
regular citizens | 9 |
todas las | 9 |
guided grad | 9 |
epidemic status | 9 |
viral transmission | 9 |
care facilities | 9 |
intravenous infusion | 9 |
group i | 9 |
urban area | 9 |
por encima | 9 |
carrier protein | 9 |
psychological responses | 9 |
based analysis | 9 |
previous report | 9 |
significant positive | 9 |
rna gene | 9 |
en todos | 9 |
colleagues reported | 9 |
serum antibody | 9 |
eye protection | 9 |
surgical masks | 9 |
pacientes adultos | 9 |
three times | 9 |
initial values | 9 |
african countries | 9 |
community containment | 9 |
many people | 9 |
coronavirus may | 9 |
rna detection | 9 |
computed tomographic | 9 |
cardiac troponin | 9 |
probability density | 9 |
oral colistin | 9 |
contra el | 9 |
oral decontamination | 9 |
evitar el | 9 |
compassionate use | 9 |
negative emotions | 9 |
transmission may | 9 |
gwr model | 9 |
old man | 9 |
ic del | 9 |
replacement therapy | 9 |
universal exchange | 9 |
tmp smx | 9 |
ijerph sha | 9 |
common clinical | 9 |
acid amplification | 9 |
seven patients | 9 |
confirmation rate | 9 |
young children | 9 |
factors affecting | 9 |
china medical | 9 |
por los | 9 |
type variants | 9 |
binomial distribution | 9 |
farming horses | 9 |
fatality rates | 9 |
probability matrix | 9 |
among crkp | 9 |
conferring resistance | 9 |
para determinar | 9 |
crkp strains | 9 |
novel wuhan | 9 |
mcr genes | 9 |
binding sites | 9 |
soporte ventilatorio | 9 |
gut microbiomes | 9 |
significantly increased | 9 |
work resuming | 9 |
seeking behavior | 9 |
human protein | 9 |
serum samples | 9 |
isolation locations | 9 |
previous years | 9 |
bacterial infection | 9 |
igm antibodies | 9 |
seguridad del | 9 |
first phase | 9 |
strong evidence | 9 |
china based | 9 |
study provides | 9 |
bal fluids | 9 |